BMI View: Chinese investment in Ecuador's pharmaceutical and healthcare sector will continue to be
pertinent for the country in order for it to meet the increasing demand of medicines within its public
healthcare sector. Foreign generic drugmakers will, however, face ..."
BMI View: Pharmaceutical companies will continue to benefit from Ecuador's growing demand for
medicines due to the government's commitment to healthcare. Going forward, we expect the government to
continue increasing national health spending, take steps to expand publ ..."
BMI View: The steadily growing Ecuadorian pharmaceutical market will provide revenue-earning
opportunities for multinational drugmakers. Because Ecuador utilises the US dollar, the country will be
more appealing to drugmakers which report in the currency, particularly ..."
BMI View: Ecuador's booming medical tourism industry, aligned with its widening negative trade balance
and hiking burden of non-communicable diseases, will ensure its strong generation of commercial
opportunities over the long term. The country's fast-growing medical ..."
BMI View: A growing demand for imported medicines, increasing rates of medical tourism and the
government's legalisation of tax incentives for foreign business will aid in improving Ecuador's appeal to
multinational pharmaceutical companies over the next ten years. Th ..."